2023
DOI: 10.33963/kp.a2023.0059
|View full text |Cite
|
Sign up to set email alerts
|

Implementation of remote monitoring in patients implanted with T-ICD and S-ICD involved in a recall campaign: An excellent tool with insufficient availability

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…Similarly, in 2021, the Pediatric and Congenital Electrophysiology Society (PACES) recognized RM as an integral part of pediatric patients' follow-up after CIED implantation [2]. The breakthrough that led to establishing RM as the standard of care in the daily practice of patients with CIED was possible due to an extensive body of evidence presenting reduced time from the onset of ventricular and supraventricular arrhythmias (including silent arrhythmias) to their evaluation, early identification of lead or device malfunction and monitoring battery status [3][4][5][6]. In contrast to the RM of high-energy devices in adults with heart failure (HF), there is no clear evidence of improved prognosis in the pediatric population, yet.…”
Section: Introductionmentioning
confidence: 99%
“…Similarly, in 2021, the Pediatric and Congenital Electrophysiology Society (PACES) recognized RM as an integral part of pediatric patients' follow-up after CIED implantation [2]. The breakthrough that led to establishing RM as the standard of care in the daily practice of patients with CIED was possible due to an extensive body of evidence presenting reduced time from the onset of ventricular and supraventricular arrhythmias (including silent arrhythmias) to their evaluation, early identification of lead or device malfunction and monitoring battery status [3][4][5][6]. In contrast to the RM of high-energy devices in adults with heart failure (HF), there is no clear evidence of improved prognosis in the pediatric population, yet.…”
Section: Introductionmentioning
confidence: 99%